BridgeBio announces in a Globe Newswire release that Ahmad Masri, M.D., will present on advances in prognostication and management of cardiac amyloidosis on Nov. 17 during an American Heart Association conference in Chicago.

Highlights from the 2024 American Association for Cancer Research special conference on pancreatic cancer research include a presentation from Teresa Zimmers, Ph.D., who provided a review of preclinical research into inflammation and cachexia.

HemOnc Today interviews Eric Roeland, M.D., about a recent New England Journal of Medicine publication highlighting positive findings from a phase II clinical trial for patients with cachexia. Roeland says, “We had 10 participants at our site and, early on in the study, I could tell there was something different happening. This is an exciting first step toward an intervention that may have profound implications on how we support patients as people going through their cancer treatment.”

Annie Hung, M.D., speaks with KOIN-TV about the importance of screening and early detection for patients with breast cancer. She says, “For Stage 1 breast cancer, the overall survival rate can be over 99% for a five-year period. These patients can be cured, and the long-term outcome is excellent. During the pandemic, unfortunately, we did have a lot of people who missed out on their screenings. And so we are seeing people diagnosed at more advanced stages.”

A team of OHSU surgeons this year performed the region’s first fetoscopic repair for spina bifida, which can significantly improve long-term health outcomes for babies born with the condition.

Life Flight, owned by a consortium that includes OHSU, announces in a PR Newswire release that it has installed a special oxygen delivery system in one of its fixed-wing airplanes.

New OHSU research illuminates the complete structure of a protein linked to health issues ranging from cancer to nerve pain to brain disorders. In an OHSU News story, Steven Mansoor, M.D., Ph.D., says, “We are really interested in understanding how the seven P2X receptor subtypes differ from each other at a molecular level. This is important because if you wanted to design a drug that blocks the activation of P2X7, you do not want to affect the function of other receptors.”

News outlets cover the latest CDC statistics revealing that illicit drug overdoses remain elevated in Oregon over the past year compared of the rest of the country, noting that dangerously potent illicit fentanyl arrived on the West Coast later than other areas of the country. Todd Korthuis, M.D., tells The Lund Report.

Healio records a video perspective by Benjamin Hoffman, M.D., president of the American Academy of Pediatrics, regarding policies on opioids in pain management for kids; promoting early childhood reading; and overzealous discipline for students who are neurodivergent, have behavioral issues or have experienced significant trauma. Regarding the last issue, he says, “We are hoping to move past a culture where suspension and expulsion were the answer and more toward a trauma-informed, inclusive approach to ensuring that every child has access to education and the resources they need to be able to learn and thrive."

Medical Ethics Advisor covers a study by Sammie Lyons, M.D., that examines how ethical issues are handled for 18- to 26-year-olds who are sometimes cared for in pediatric settings and sometimes adult settings. She notes that at OHSU, there is a single ethics committee for both adult and pediatric patients, which is better for young adults. “When dividing an ethics committee into pediatric and adult subgroups, you are missing this particular patient panel that traverses both spaces,” she says.